Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Features
100%
Patient Survival
100%
Lung Function
100%
Antinuclear Antibodies
100%
Systemic Sclerosis
100%
Antibody Function
100%
RNA-dependent RNA Polymerase (RdRP)
40%
Topos
40%
Right Heart Failure
30%
Diffuse Systemic Sclerosis
30%
Nephropathy
20%
Disease Course
10%
Clinical Variables
10%
Cause of Death
10%
Cardiac Disease
10%
Relative Risk
10%
Clinical Status
10%
Observation Period
10%
Autoantibodies
10%
Prognostic Value
10%
Immunofluorescence
10%
Cox Regression Model
10%
Antisense
10%
New Patients
10%
Pulmonary Function
10%
Laboratory Parameters
10%
Disease Onset
10%
Cutaneous Involvement
10%
Pulmonary Fibrosis
10%
Double Immunodiffusion
10%
Cutaneous Sclerosis
10%
Related Conditions
10%
Hemagglutination
10%
Diffuse Cutaneous
10%
Early Course
10%
Status Functions
10%
Riboprobe
10%
Anticentromere
10%
Anti-topoisomerase I Antibodies
10%
Vital Status
10%
Onset Time
10%
U1 snRNP
10%
Medicine and Dentistry
Clinical Feature
100%
Antinuclear Antibody
100%
Systemic Scleroderma
100%
Lung
100%
RNA Polymerase
30%
Heart Right Ventricle Failure
23%
Ribonucleoprotein
23%
Nephropathy
15%
DLCO
15%
Diseases
15%
Heart Disease
7%
Immunofluorescence
7%
Autoantibodies
7%
Enzyme Linked Immunosorbent Assay
7%
Morbidity
7%
Sclerosis
7%
Lung Function
7%
Antisense
7%
Red Cell Agglutination
7%
Pulmonary Fibrosis
7%
Cox Regression Model
7%
Status Function
7%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Feature
100%
Antinuclear Antibody
100%
Systemic Sclerosis
100%
RNA Polymerase
30%
Heart Right Ventricle Failure
23%
Ribonucleoprotein
23%
Kidney Disease
15%
Diseases
15%
Heart Disease
7%
Enzyme-Linked Immunosorbent Assay
7%
Morbidity
7%
Autoantibodies
7%
Sclerosis
7%
Lung Fibrosis
7%
Immunology and Microbiology
Systemic Scleroderma
100%
Antinuclear Antibody
100%
Lung
100%
RNA Polymerase
30%
Autoantibodies
7%
Immunofluorescence
7%
ELISA
7%
Antisense
7%
Lung Function
7%
Morbidity
7%
Immunodiffusion
7%
Hemagglutination
7%